Fmr LLC Trims Stake in Maximus, Inc. (NYSE:MMS)

FMR LLC decreased its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 5.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 8,362,049 shares of the health services provider's stock after selling 462,909 shares during the quarter. FMR LLC owned about 14.64% of Maximus worth $624,227,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Verition Fund Management LLC increased its holdings in shares of Maximus by 83.3% during the 3rd quarter. Verition Fund Management LLC now owns 8,331 shares of the health services provider's stock valued at $776,000 after purchasing an additional 3,786 shares in the last quarter. EP Wealth Advisors LLC purchased a new stake in shares of Maximus during the third quarter worth $269,000. XTX Topco Ltd lifted its stake in Maximus by 234.1% in the 3rd quarter. XTX Topco Ltd now owns 11,879 shares of the health services provider's stock worth $1,107,000 after purchasing an additional 8,324 shares in the last quarter. MML Investors Services LLC boosted its position in shares of Maximus by 6.5% during the 3rd quarter. MML Investors Services LLC now owns 4,870 shares of the health services provider's stock valued at $454,000 after acquiring an additional 299 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new stake in shares of Maximus in the 3rd quarter valued at approximately $1,008,000. Institutional investors own 97.21% of the company's stock.

Insiders Place Their Bets

In related news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Remove Ads

Maximus Stock Up 0.4 %

MMS stock traded up $0.29 during midday trading on Monday, hitting $68.79. The company's stock had a trading volume of 49,370 shares, compared to its average volume of 547,550. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The firm has a 50-day simple moving average of $67.90 and a 200-day simple moving average of $76.04. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm has a market capitalization of $3.89 billion, a P/E ratio of 14.79 and a beta of 0.68.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, equities analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be paid a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.74%. Maximus's dividend payout ratio is currently 25.81%.

Wall Street Analyst Weigh In

MMS has been the subject of several research analyst reports. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd. StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.